TNFRSF18
| Symbol | TNFRSF18 |
|---|---|
| HGNC ID | 11907 |
| Alternative symbols | – |
| Entrez Gene | 8784 |
| OMIM | 604501 |
| RefSeq | NM_004195 |
| UniProt | Q9Y5U5 |
| Chromosome | 1p36.33 |
| Locus supplementary data | – |
TNFRSF18 (Tumor Necrosis Factor Receptor Superfamily Member 18), also known as GITR (Glucocorticoid-Induced TNFR-Related protein), is a protein that in humans is encoded by the TNFRSF18 gene. This gene is part of the tumor necrosis factor receptor superfamily, which plays a crucial role in the regulation of immune responses.
Function[edit]
TNFRSF18 is primarily expressed on the surface of regulatory T cells (Tregs) and activated T lymphocytes. It is involved in the modulation of immune system functions, particularly in the context of autoimmunity and inflammation. The interaction of TNFRSF18 with its ligand, GITRL (Glucocorticoid-Induced TNFR-Related Ligand), can lead to the activation of NF-kB and MAPK pathways, promoting T cell proliferation and survival.
Clinical Significance[edit]
The TNFRSF18-GITRL interaction has been implicated in various autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. It is also being studied for its potential role in cancer immunotherapy, as modulating this pathway could enhance anti-tumor immune responses.
Research[edit]
Research on TNFRSF18 is ongoing to better understand its role in immune regulation and its potential as a therapeutic target. Studies are exploring the use of agonistic antibodies to stimulate TNFRSF18, which could enhance the immune system's ability to fight cancer and chronic infections.
See Also[edit]
- Tumor necrosis factor receptor superfamily
- Regulatory T cell
- Autoimmune disease
- Cancer immunotherapy
References[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian